Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 18 articles: HTML format

Single Articles

September 2025
1. KIM J, Shrestha C, Lee G, Jung D, et al
   Condensation of the Golgi Apparatus Activates YAP1 to Promote Gastric Cancer Progression.
   Cancer Res. 2025 Sep 8. doi: 10.1158/0008-5472.CAN-24-3920.
   PubMed     Abstract available
   
   
   August 2025
2. CONTICELLI D, Volante M, Pietrantonio F, Orru C, et al
   AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.
   Cancer Res. 2025;85:3111-3122.
   PubMed     Abstract available
   
   
   May 2025
3. XU X, Yan C, Bian L, Li Z, et al
   Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer.
   Cancer Res. 2025 May 16. doi: 10.1158/0008-5472.CAN-24-4065.
   PubMed     Abstract available
   
   
   
4. KUAI X, Li L, Chen R, Wang K, et al
   Correction: SCFFBXW7/GSK3beta-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.
   Cancer Res. 2025;85:1739.
   PubMed    
   
   
   April 2025
5. QIU B, Zheng Y, Liu S, Song R, et al
   Multi-task Deep Learning Based on Longitudinal CT Images Facilitates Prediction of Lymph Node Metastasis and Survival in Chemotherapy-Treated Gastric Cancer.
   Cancer Res. 2025 Apr 30. doi: 10.1158/0008-5472.CAN-24-4190.
   PubMed     Abstract available
   
   
   March 2025
6. LIN GT, Yan C, Li LJ, Qiu XW, et al
   Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.
   Cancer Res. 2025 Mar 7. doi: 10.1158/0008-5472.CAN-24-2697.
   PubMed     Abstract available
   
   
   February 2025
7. ZHANG T, Li Y, Zhai E, Zhao R, et al
   Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion.
   Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2580.
   PubMed     Abstract available
   
   
   October 2024
8. CUI Y, Chang Y, Ma X, Sun M, et al
   Ephrin A1 Stimulates CCL2 Secretion to Facilitate Pre-metastatic Niche Formation and Promote Gastric Cancer Liver Metastasis.
   Cancer Res. 2024 Oct 16. doi: 10.1158/0008-5472.CAN-24-1254.
   PubMed     Abstract available
   
   
   July 2024
9. LIU X, Chen B, Xie F, Wong KY, et al
   FOXP4 is a Direct YAP1 Target that Promotes Gastric Cancer Stemness and Drives Metastasis.
   Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3074.
   PubMed     Abstract available
   
   
   
10. LIU S, Lin C, Lin X, Lin P, et al
    NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-23-4062.
    PubMed     Abstract available
    
    
    
11. GNANAPRAGASAM A, Kirbizakis E, Li A, White KH, et al
    HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.
    Cancer Res. 2024;84:2377-2389.
    PubMed     Abstract available
    
    
    December 2023
12. TU RH, Wu SZ, Huang ZN, Zhong Q, et al
    Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.
    Cancer Res. 2023;83:3868-3885.
    PubMed     Abstract available
    
    
    September 2023
13. FAN Y, Song S, Li Y, Dhar SS, et al
    Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases.
    Cancer Res. 2023 Sep 22. doi: 10.1158/0008-5472.CAN-23-0783.
    PubMed     Abstract available
    
    
    August 2023
14. YE H, Shi W, Yang J, Wang L, et al
    PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
    Cancer Res. 2023 Aug 30. doi: 10.1158/0008-5472.CAN-23-1331.
    PubMed     Abstract available
    
    
    May 2023
15. PETRELLI A, Rizzolio S, Pietrantonio F, Bellomo SE, et al
    BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
    Cancer Res. 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
    PubMed     Abstract available
    
    
    March 2023
16. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2023;83:804.
    PubMed    
    
    
    
17. TAURIELLO DVF
    Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy.
    Cancer Res. 2023;83:655-656.
    PubMed     Abstract available
    
    
    
18. AKIYAMA T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, et al
    Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
    Cancer Res. 2023;83:753-770.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.